Hans Klingemann

Hans Klingemann

Chief Tech/Sci/R&D Officer at IMMUNITYBIO, INC.
76 year
Health Technology
Consumer Services
Health Services

Profile

Hans Georg Klingemann was the founder of NantKwest, Inc. (founded in 2002) where he held the title of Director, Chief Medical & Scientific Officer from 2012 to 2015.
He is currently the Chief Science Officer–Cellular at ImmunityBio, Inc. Dr. Klingemann's former positions include being an Independent Non-Executive Director at Osiris Therapeutics, Inc. from 2012 to 2016, Director-Bone Marrow Transplant at Rush University Medical Center, Director at Bone Marrow & Cancer Foundation, Inc., and Director-Stem Cell Transplant at Tufts Medical Center, Inc.Dr. Klingemann obtained a doctorate degree from Philipps University of Marburg and the University of Würzburg Medical School.

Hans Klingemann active positions

CompaniesPositionStart
IMMUNITYBIO, INC. Chief Tech/Sci/R&D Officer -

Former positions of Hans Klingemann

CompaniesPositionEnd
OSIRIS THERAPEUTICS, INC. Director/Board Member 11/06/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
IMMUNITYBIO, INC. Founder -
See the detail of Hans Klingemann's experience

Training of Hans Klingemann

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Consumer Services

Health Services

Commercial Services

Health Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Hans Klingemann